We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Single PCR Test Simultaneously Detects 12 Respiratory Viruses in Same Patient Sample

By LabMedica International staff writers
Posted on 25 Sep 2024
Print article
Image: TAGS technology enables syndromic panel testing on the high throughput molecular diagnostic analyzers cobas 5800, 6800 and 8800 (Photo courtesy of Roche)
Image: TAGS technology enables syndromic panel testing on the high throughput molecular diagnostic analyzers cobas 5800, 6800 and 8800 (Photo courtesy of Roche)

Many respiratory illnesses share similar symptoms, making diagnosis challenging. As respiratory outbreaks and antibiotic resistance rise, timely and accurate diagnosis is crucial for providing optimal patient care and preventing transmission. A new test now enables clinicians to identify up to 12 of the most common respiratory viruses, helping to speed up diagnosis and deliver appropriate care.

Roche (Basel, Switzerland) has introduced the cobas Respiratory flex test, the first to utilize the company’s innovative TAGS (Temperature-Activated Generation of Signal) technology. Developed by Roche scientists, TAGS technology combines multiplex polymerase chain reaction (PCR) testing with color, temperature, and data processing to detect up to 15 pathogens in a single test. Traditional PCR tests typically detect only four results in a single test. TAGS technology, however, can differentiate up to three targets per fluorescence channel, allowing the detection of up to 15 diagnostic results from a single kit. This novel, proprietary approach overcomes the limitations of previous 4-plex testing solutions, facilitating syndromic panel testing on the high-throughput cobas 5800, 6800, and 8800 molecular diagnostic analyzers, which is essential when symptoms could be linked to multiple pathogens. Existing cobas 5800, 6800, and 8800 systems can immediately deliver fast, accurate, high-throughput multiplex PCR testing without requiring hardware or software upgrades. Additionally, Roche’s TAGS technology has the potential for broader applications across various pathogens and indications, offering the possibility of transforming high-throughput testing for infectious diseases in the future.

The cobas Respiratory flex test detects up to 12 common respiratory viruses, including influenza A, influenza B, Respiratory Syncytial Virus (RSV), and SARS-CoV-2, from a single patient sample using one PCR test. The test also allows clinicians to select specific pathogens based on factors like the test setting, season, locality, and patient-specific needs. For instance, during winter, a clinician might use the test to determine if a healthy adult patient has influenza or SARS-CoV-2, which are common during that time. Typically, diagnosing a patient requires testing a specific group of pathogens first, which can delay results if follow-up tests are needed. The cobas Respiratory flex test eliminates this delay with its digital reflex feature, enabling immediate generation of additional results without needing a new sample or retesting the original sample. This test delivers comprehensive results from a single PCR, simplifying lab operations and easing logistical challenges, while optimizing resource use. The test is now available in countries that accept CE marking, and several countries have begun their local registration processes. The U.S. FDA 510(k) clearance is expected following submission in Q4.

“Many respiratory illnesses share similar symptoms, making them difficult to diagnose. As respiratory outbreaks, combined with growing incidence of antibiotic resistance continue, getting an accurate and timely diagnosis is critical to providing the best care for patients and curbing transmission,” said Matt Sause, CEO of Roche Diagnostics. “Using TAGS technology, the cobas Respiratory flex test can help clinicians identify specific respiratory viruses sooner, helping to speed up diagnosis and get the right care to patients.”

Gold Member
Turnkey Packaging Solution
HLX
Unit-Dose Packaging solution
HLX
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Respiratory Syncytial Virus Test
QuickVue RSV Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.